Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Virion Therapeutics, LLC
*MAILING ADDRESS
7 Creek Bend Court
*CITY
Newark
*STATE
(Required for U.S. applicants)
Delaware
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
19711
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Vaccine platform, namely, namely an adenovirus vector platform for applications in vaccines for infectious diseases; vaccines for humans;
human vaccine preparations; therapeutic vaccines for humans
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Biomedical research services; research and development of vaccines and medicines; research, development, engineering and testing services in
the fields of immunopharmaceuticals and vaccines; scientific research; scientific research in the field of vaccines; clinical and pre-clinical development services
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Kevin M. Bovard
ATTORNEY DOCKET NUMBER
111876.00045
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Baker & Hostetler LLP
INTERNAL ADDRESS
Suite 3300
STREET
1735 Market Street
CITY
Philadelphia
STATE
Pennsylvania
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
19103-7501
PHONE
215-568-3100
FAX
215-568-3439
EMAIL ADDRESS
bhipdocket@bakerlaw.com
OTHER APPOINTED ATTORNEY
Nancy Rubner Frandsen, Jacqueline M. Lesser, Lesley M. Grossberg, Lisa Bollinger Gehman, Candice Reder, Mark H. Tidman, Robert B.G.
Horowitz, John M. Mueller, Deborah A. Wilcox, Kevin Wallace, Gabrial L. Mitchell
CORRESPONDENCE INFORMATION
NAME
Kevin M. Bovard
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
bhipdocket@bakerlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
kbovard@bakerlaw.com; jdale@bakerlaw.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
700
*TOTAL FEES PAID
700
SIGNATURE INFORMATION
SIGNATURE
/Susan Currie/
SIGNATORY'S NAME
Susan Currie
SIGNATORY'S POSITION
Chief Operating Officer
SIGNATORY'S PHONE NUMBER
1-415-806-4501
DATE SIGNED
02/10/2022
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97262974
Filing Date:02/11/2022
To the Commissioner for Trademarks:
MARK: CHIVAX (Standard Characters, see mark)
The literal element of the mark consists of CHIVAX. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Virion Therapeutics, LLC, a limited liability company legally organized under the laws of Delaware, having an address of
7 Creek Bend Court
Newark, Delaware 19711
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Vaccine platform, namely, namely an adenovirus vector platform for applications in vaccines for infectious diseases; vaccines for humans; human vaccine preparations;
therapeutic vaccines for humans
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Biomedical research services; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of
immunopharmaceuticals and vaccines; scientific research; scientific research in the field of vaccines; clinical and pre-clinical development services
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Kevin M. Bovard. Other appointed attorneys are Nancy Rubner Frandsen, Jacqueline M. Lesser, Lesley M. Grossberg, Lisa Bollinger Gehman, Candice
Reder, Mark H. Tidman, Robert B.G. Horowitz, John M. Mueller, Deborah A. Wilcox, Kevin Wallace, Gabrial L. Mitchell. Kevin M. Bovard of Baker & Hostetler LLP, is a member of the XX bar,
admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Suite 3300
1735 Market Street
Philadelphia, Pennsylvania 19103-7501
United States
215-568-3100(phone)
215-568-3439(fax)
bhipdocket@bakerlaw.com
The docket/reference number is 111876.00045.
Kevin M. Bovard submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Susan Currie/ Date: 02/10/2022
Signatory's Name: Susan Currie
Signatory's Position: Chief Operating Officer
Signatory's Phone Number: 1-415-806-4501
Signature method: Sent to third party for signature
Payment Sale Number: 97262974
Payment Accounting Date: 02/11/2022
Serial Number: 97262974
Internet Transmission Date: Fri Feb 11 10:52:52 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202202111052523
74206-97262974-81094ab4324db42f880491f1f
6c74adb3aa11ad143cea3df563a8fdc2316a2e62
4-DA-52520384-20220209154714735307